New research by Dr Claire Vale (UCL Institute of Clinical Trials & Methodology) helps pinpoint prostate cancer suffers who might benefit the most from aggressive chemotherapy, and who should get alternate treatment with fewer side effects.
Read: Telegraph, More: Times (£), Express, Mail Online
Close
